| [1] |
Xue Pengcheng, Liu Zengye, Wu Jinyuan, Ma Cheng.
Effect of anti-vascular endothelial growth factor on outer retinal structure restoration of diabetic macular edema
[J]. Clinical Focus, 2022, 37(9): 817-821.
|
| [2] |
Qiu Jianmei, Shen Hongxia, Wang Defeng.
Multiple system atrophy complicated with syndrome of inappropriate antidiuresis: A case report and literature review
[J]. Clinical Focus, 2022, 37(5): 451-454.
|
| [3] |
Chen Guangpeng, Miao Guoyin, Yang Yanqin.
Relationship between expression of serum vascular endothelial growth factor, procalcitonin, high-sensitivity C-reactive protein and severity of cerebral edema in patients with acute cerebral infarction
[J]. Clinical Focus, 2021, 36(4): 315-318.
|
| [4] |
Liu Lunzhi, Deng Lu, Zhang Mingxia.
Effects of angiotensin Ⅱ type 1 receptor blockers on urinary nephrin and Beclin-1 mRNA excretion in urine of patients with early diabetic nephropathy
[J]. Clinical Focus, 2021, 36(11): 1005-1008.
|
| [5] |
Zhu Ran, Chinese Critical Ultrasound Study Group.
Appropriate application of furosemide stress test
[J]. Clinical Focus, 2019, 34(7): 614-616.
|
| [6] |
Wang Rongzhen1, Yao Can1, Liu Feng2.
Relationship between nephrin and prognosis of diabetic nephropathy
[J]. Clinical Focus, 2019, 34(5): 431-435.
|
| [7] |
Mao Weiwei, Dong Ping.
Correlation analysis on serum level of 25hydroxy vitamin D3 and lipoproteinassociated phospholipase A2 with early diabetic nephropathy
[J]. Clinical Focus, 2019, 34(10): 911-914.
|
| [8] |
Dong Lia, Zhao Jihaib.
Effects of liraglutide on renal function in patients with microalbuminuria of diabetic nephropathy
[J]. Clinical Focus, 2018, 33(5): 420-423.
|
| [9] |
Gao Yan1, Li Linqian2, Wang Qian2, Zhang Si2, Zhang Haisong1.
Hepatokines in pathogenesis of diabetic nephropathy
[J]. Clinical Focus, 2018, 33(10): 859-862.
|
| [10] |
Yang Han, Li Shaomei.
Renal biopsy in diagnosis of diabetic kidney disease
[J]. Clinical Focus, 2018, 33(10): 854-858.
|
| [11] |
Luo Jiakai， Li Zhihong， Yin Fei， Yuan Xiaochao， Wang Xin.
Clinical characteristics and risk factors in type 2 diabetic nephropathy
[J]. Clinical Focus, 2017, 32(9): 763-766.
|
| [12] |
Xu Naa， Guo Shuqina， Zhang Yunlianga， Ma Jingxuana，Wang Hea， .
Relationship study between serum secreted frizzledrelated protein 5 level and diabetic nephropathy
[J]. Clinical Focus, 2017, 32(3): 233-236.
|
| [13] |
Wang Jiapei1，Wu Ling2，Wang Tianbo2，Zheng Jika2，Di Yazhen2，Dai Xiahua2.
Prognosis and treatment of children in HenochSchnlein purpura with angioneurotic edema
[J]. Clinical Focus, 2017, 32(1): 68-70.
|
| [14] |
Xing Lingling1， Song Hongwang2， Zhang Chunxia1， LI Shaomei1， Yang Lin1.
Role of PTEN and desmin in patients with diabetic nephropathy
[J]. Clinical Focus, 2016, 31(8): 897-900.
|
| [15] |
ZHOU Bin;ZHOU Ying-li;FU Yu;SHI Peng;LIN Wei-min;CAO Jia-yue.
Effect of alprostadil combined with Shenmai or astragalus in treatment of diabetic nephropathy
[J]. Clinical Focus, 2014, 29(7): 724-727.
|
